Shares in the drugmaker have fallen more than 50 per cent in the past 12 months, causing it to lose its crown as Europe’s largest listed company by market capitalisation ... These cheaper alternatives ...

Lars Fruergaard Jorgensen, the chief executive of once-highflying Danish drugmaker Novo Nordisk, is stepping down after eight ...

Novo Nordisk CEO steps down after pressure from shareholders. Former CEO to join board as observer. Company remains ...